{
    "2019-07-11": [
        [
            {
                "time": "",
                "original_text": "科伦药业创仿结合发力自主研发 药物制剂业务销售或超百亿",
                "features": {
                    "keywords": [
                        "科伦药业",
                        "创仿结合",
                        "自主研发",
                        "药物制剂",
                        "销售"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "锦欣生殖上市遇冷 “不孕不育”蓝海变局隐现",
                "features": {
                    "keywords": [
                        "锦欣生殖",
                        "上市遇冷",
                        "不孕不育",
                        "蓝海变局"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药：药品研发多点开花，业绩有望逐季加速",
                "features": {
                    "keywords": [
                        "复星医药",
                        "药品研发",
                        "多点开花",
                        "业绩",
                        "逐季加速"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-11",
                "original_text": "【信达看盘】2019.7.11",
                "features": {
                    "keywords": [
                        "信达看盘",
                        "2019.7.11"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "融资客青睐23股，华孚时尚买入占比高达65.30%",
                "features": {
                    "keywords": [
                        "融资客",
                        "青睐",
                        "华孚时尚",
                        "买入占比",
                        "65.30%"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "纺织服装"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}